Abstract:Introduction Transcatheter aortic valve replacement (TAVR) has gained steam within the last decade and widened the patient population eligible for aortic valve replacement. When compared to the surgical aortic valve replacement approach (SAVR), TAVR approach has been documented with the least incidence of complications and shorter length of hospital stay in the appropriate patient demographic. Objective We aim to estimate the five-year readmission trends, burden, and outcomes on heart failure patients who had TAVR procedure. Methods We retrospectively analyzed the readmissions tracked in the National Readmission database over a five year period from January 1, 2016, to December 31, 2020. Patients with an index admission and readmission corresponding ICD codes for TAVR and heart failure were used. Parameters of statistical interest included fatality rate in index admission, readmission rate, etiologies of readmission, and predictor of readmission, all these outcomes were stratified by the index year. Results About 315,937 index admissions for TAVR were recorded with an estimated 0.04% (106) all-cause readmission within 30-days of discharge. The average index admission fatality rate within the five-year period was 0.99%. Valvular stenosis (27.80%), valve leakage (12.27%), and other mechanical valve complications (18.72%) were the most common causes of readmission. A 30-day readmission due to heart failure were seldom and figured among the top three in 2016 (2.09%). Despite almost a twofold increase in the number of TAVR performed from 2016 to 2020, the 30-day readmission rate has remained steady, and the index fatality rate trended downwards. Conclusion About 1 in 100 patients who had TAVR procedure suffered mortality during their index admission. The major cause of readmission in the five year period studied was valvular stenosis and valve leakage. Heart failure readmissions in the TAVR population were already on a downward trend based on earlier data. More information is needed to understand the role played by improvement in procedures and the vulgarization of SGLT2 inhibitors around 2014.

Trends in Complications Among Patients Undergoing Aortic Valve Replacement in the United States

Trends in Complications among Patients undergoing Aortic Valve Replacement (AVR) in the United States

Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States

Abstract 19137: Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcutaneous Aortic Valve Replacement: Experience from the PARTNER Continued Access Registry

Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018

Over a Decade of Practice

Surgical versus Transcatheter Aortic Valve Replacement in Low Risk Medicare Beneficiaries

30-Day Outcomes after Surgical or Transapical Aortic Valve Replacement in Symptomatic Aortic Regurgitation

Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials

Early and Mid-Term Outcomes of Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: Updated Systematic Review and Meta-Analysis

National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement

Meta-Analysis Comparing Results of Transcatheter Versus Surgical Aortic-Valve Replacement in Patients With <i>Severe</i> Aortic Stenosis

Guidelines Versus Practice: Surgical Versus Transcatheter Aortic Valve Replacement in Adults < 60 Years

An Analysis Regarding the Article: Insight Into the Optimal Timing of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement

Long-term risk of reintervention after transcatheter aortic valve replacement

Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations

Midterm Outcome of Transcatheter Versus Surgical Aortic Valve Replacement in Low to Intermediate Risk Patients: A Meta-Analysis of Randomized Controlled Trials.

Novel Techniques and Technologies for Surgical Aortic Valve Replacement: A Large Retrospective Cohort Analysis

Long-Term Outcomes After Transcatheter Aortic Valve Replacement: Meta-Analysis of Kaplan-Meier-Derived Individual Patient Data

Five-Year Readmission Trends, Burden, And Outcome Of Transcatheter Aortic Valve Replacement With Heart Failure

Comparative Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Elderly Patients With Severe Symptomatic Aortic Stenosis: A Systematic Review